Published in Int J Tuberc Lung Dis on July 01, 1998
Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol (1998) 2.27
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis (2008) 2.26
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol (2002) 1.57
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes (2012) 1.10
Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol (2004) 1.00
Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health (2009) 0.87
Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health (2015) 0.86
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health (2016) 0.79
The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB. PLoS Comput Biol (2016) 0.75
Polymerase chain reaction for detection of Mycobacterium tuberculosis. J Clin Microbiol (1990) 5.55
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
Usefulness of spoligotyping To discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol (1999) 2.39
Improved microscopical diagnosis of pulmonary tuberculosis in developing countries. Trans R Soc Trop Med Hyg (1995) 2.38
Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol (1998) 2.27
Evaluation of polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy for the detection of Mycobacterium tuberculosis in sputum. J Infect Dis (1992) 2.24
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23
Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis. Int J Tuberc Lung Dis (2004) 1.93
Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci. Infect Immun (1983) 1.89
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76
Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis (1998) 1.75
Absorbable versus non-absorbable suture in carpal tunnel decompression. J Hand Surg Br (2001) 1.60
[Tuberculosis in Denmark 1972-1996]. Ugeskr Laeger (1999) 1.60
Fluorescence In situ hybridization assay using peptide nucleic acid probes for differentiation between tuberculous and nontuberculous mycobacterium species in smears of mycobacterium cultures. J Clin Microbiol (1999) 1.58
AIDS and Mycobacterium avium serovars in Sweden. Lancet (1989) 1.55
Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007. Int J Tuberc Lung Dis (2009) 1.52
Long-term course of Mycobacterium tuberculosis infection in Swedish birth cohorts during the twentieth century. Int J Tuberc Lung Dis (2011) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur J Clin Microbiol Infect Dis (2001) 1.45
Tenosynovitis of the hand caused by Mycobacterium terrae. Eur J Clin Microbiol Infect Dis (1989) 1.35
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. J Antimicrob Chemother (2010) 1.34
Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis (1994) 1.33
Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.33
Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J Clin Microbiol (1995) 1.33
Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl (1997) 1.31
Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect (2003) 1.10
DNA fingerprinting of Mycobacterium tuberculosis strains from patients with pulmonary tuberculosis in Honduras. J Clin Microbiol (1997) 1.10
High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis (1980) 1.08
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol. J Antimicrob Chemother (1998) 1.04
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Isoelectric points and surface hydrophobicity of Gram-positive cocci as determined by cross-partition and hydrophobic affinity partition in aqueous two-phase systems. Infect Immun (1982) 1.01
Regulation of mitogen-induced lymphocyte DNA synthesis by human interferon of different origins. Cell Immunol (1978) 0.97
Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis (2001) 0.95
Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate. J Antimicrob Chemother (1993) 0.93
IDH mutation status in prostate cancer. Oncogene (2011) 0.93
The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant (2013) 0.92
Effect of specific binding of human albumin, fibrinogen, and immunoglobulin G on surface characteristics of bacterial strains as revealed by partition experiments in polymer phase systems. Infect Immun (1980) 0.92
Does vaccination with bacille Calmette-Guérin protect against AIDS? Rev Infect Dis (1989) 0.92
Evaluation of four qualitative methods for detection of beta-lactamase production in Staphylococcus and Micrococcus species. Eur J Clin Microbiol Infect Dis (1989) 0.91
Antimycobacterial synergism of clarithromycin and rifabutin. Scand J Infect Dis (1996) 0.91
Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg (2000) 0.91
Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle. J Gen Virol (1979) 0.90
Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis (1998) 0.89
Evaluating the usefulness of spa typing, in comparison with pulsed-field gel electrophoresis, for epidemiological typing of methicillin-resistant Staphylococcus aureus in a low-prevalence region in Sweden 2000-2004. Clin Microbiol Infect (2009) 0.89
Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun (1992) 0.89
Modulation of immune responses in newborn and adult mice by interferon. Infect Immun (1978) 0.88
Comparison of Mycobacterium avium complex (MAC) strains from pigs and humans in Sweden by random amplified polymorphic DNA (RAPD) using standardized reagents. Vet Microbiol (2001) 0.87
Interferon production in glia and glioma cell lines. Infect Immun (1978) 0.86
Comparison between comparative tuberculin and gamma-interferon tests for the diagnosis of bovine tuberculosis in Ethiopia. Trop Anim Health Prod (2000) 0.86
In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother (2001) 0.85
Variations in binding of mammalian fibrinogens to streptococci groups A, B, C, E, G and to Staphylococcus aureus. Acta Pathol Microbiol Immunol Scand B (1985) 0.84
On the interaction between beta 2-microglobulin and group A streptococci. Scand J Immunol (1984) 0.84
Hypoxia due to patent foramen ovale in the absence of pulmonary hypertension. Tex Heart Inst J (1999) 0.83
Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system. J Infect Dis (1995) 0.83
Drug-resistant Mycobacterium tuberculosis and atypical mycobacteria isolated from patients with suspected pulmonary tuberculosis in Honduras. Chest (1997) 0.82
Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution. Scand J Infect Dis (2001) 0.82
Surface characteristics of group A streptococci with and without M-protein. Acta Pathol Microbiol Immunol Scand B (1984) 0.82
Mycobacterium fortuitum complex in Sweden during an 11-year period. Scand J Infect Dis (1997) 0.82
Diagnosis of pulmonary tuberculosis. Lancet (1994) 0.82
Species-specific identification of methicillin resistance in staphylococci. Eur J Clin Microbiol Infect Dis (1995) 0.82
Evaluation of the factors related to postmastectomy breast reconstruction. Plast Reconstr Surg (2001) 0.81
The diagnosis of bacteriuria during pregnancy. Scand J Prim Health Care (1990) 0.81
Technical considerations of fibular osteocutaneous flap dissection. J Plast Reconstr Aesthet Surg (2007) 0.81
Increased growth of Mycobacterium malmoense in vitro in the presence of isoniazid. Eur J Clin Microbiol Infect Dis (1991) 0.80
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur J Clin Microbiol Infect Dis (1992) 0.80
Mycobacterium interjectum: a new pathogen in humans? Scand J Infect Dis (2000) 0.80
Sociodemographic indicators of stroke mortality. J Natl Med Assoc (1989) 0.78
Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women. Osteoporos Int (2011) 0.78
The Marshall technique: an economic one-stage technique for nipple-areola reconstruction. Br J Plast Surg (2002) 0.78
[Acanthamoeba keratitis--a new diagnosis in Sweden]. Lakartidningen (1992) 0.78
V-Y advancement flap and composite graft for alar-groove reconstruction. Br J Plast Surg (2002) 0.77
Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. Diagn Microbiol Infect Dis (1997) 0.77
In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis (2002) 0.77
Detection of Plasmodium falciparum sporozoites in naturally infected anopheline species using a fluorescein-labelled DNA probe. Acta Trop (1997) 0.76
Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges. Psychopharmacology (Berl) (1988) 0.76
Acanthamoeba keratitis in the south of Sweden. Acta Ophthalmol Scand (1996) 0.76
Subcutaneous infection of the hand due to Mycobacterium nonchromogenicum. J Hand Surg Am (1993) 0.76
Disk with high oxacillin content discriminates between methicillin-resistant and borderline methicillin-susceptible Staphylococcus aureus strains in disk diffusion assays using a low salt concentration. J Clin Microbiol (1999) 0.75
In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida. Antimicrob Agents Chemother (1989) 0.75
Bronchoscopic diagnosis of pulmonary infections in a heterogeneous, nonselected group of patients. Chest (1993) 0.75
Are strains of Mycobacterium avium more drug resistant when isolated from human immunodeficiency virus-infected patients? J Infect Dis (1992) 0.75
A new tie-over dressing for hypospadias repair. Br J Plast Surg (1999) 0.75
Novel approaches to the diagnosis of mycobacterial infections. Eur Respir J (1994) 0.75
An adolescent athlete with groin and hip pain. Emerg Med J (2010) 0.75
[Chloramphenicol resistance in acute epiglottitis--a growing problem in antibiotic therapy?]. Lakartidningen (1987) 0.75
Assay of type-specific M antigens on whole group A streptococci. Eur J Clin Microbiol (1984) 0.75
Reactions of N-N and N-O compounds with horseradish peroxidase and peroxidases from Mycobacterium tuberculosis. APMIS (1999) 0.75
Management of impotence in primary care. Compr Ther (1998) 0.75
Graft failure disclosing disseminated Mycobacterium avium-intracellulare infection. Bone Marrow Transplant (1992) 0.75
Comparison of strand displacement and ligase chain amplification for detection of Chlamydia trachomatis infection in urogenital specimens. Clin Microbiol Infect (2005) 0.75
Paracetamol in hepatosplenic bilharziasis. J Egypt Med Assoc (1978) 0.75
Anticoagulation for stroke prevention in a Medicare population with atrial fibrillation. J Fla Med Assoc (1997) 0.75
[Nalidixic acid--a forgotten alternative]. Lakartidningen (1994) 0.75
[PCR in the diagnosis of tuberculosis. A rapid, sensitive and specific technique]. Lakartidningen (1995) 0.75
[Molecular mycobacterium-diagnostics. Weapon against increased global spread of tuberculosis]. Lakartidningen (1997) 0.75
[Fiberoptic bronchoscopy--a possibility for the diagnosis of Pasteurella multocida pneumonia]. Lakartidningen (1987) 0.75
[Hydatid cyst of the spleen is an unusual diagnosis in Sweden]. Lakartidningen (1992) 0.75
Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae. Scand J Infect Dis (1994) 0.75